Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Myeloid Malignancies and the Marrow Microenvironment: Some Recent Studies in Patients with MDS.

Marcondes AM, Ramakrishnan A, Deeg HJ.

Curr Cancer Ther Rev. 2009 Nov 1;5(4):310-314.

2.

Dysregulation of IL-32 in myelodysplastic syndrome and chronic myelomonocytic leukemia modulates apoptosis and impairs NK function.

Marcondes AM, Mhyre AJ, Stirewalt DL, Kim SH, Dinarello CA, Deeg HJ.

Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):2865-70. doi: 10.1073/pnas.0712391105. Epub 2008 Feb 19.

3.

In vitro characterization of hematopoietic microenvironment cells from patients with myelodysplastic syndrome.

Flores-Figueroa E, GutiƩrrez-Espƭndola G, Montesinos JJ, Arana-Trejo RM, Mayani H.

Leuk Res. 2002 Jul;26(7):677-86.

PMID:
12008086
4.
5.

The helix-loop-helix transcription factor TWIST is dysregulated in myelodysplastic syndromes.

Li X, Marcondes AM, Gooley TA, Deeg HJ.

Blood. 2010 Sep 30;116(13):2304-14. doi: 10.1182/blood-2009-09-242313. Epub 2010 Jun 18.

6.

Special Education: Aplastic Anemia.

Teramura M, Mizoguchi H.

Oncologist. 1996;1(3):187-189.

7.

No telomere shortening in marrow stroma from patients with MDS.

Marcondes AM, Bair S, Rabinovitch PS, Gooley T, Deeg HJ, Risques R.

Ann Hematol. 2009 Jul;88(7):623-8. doi: 10.1007/s00277-008-0649-7. Epub 2008 Dec 3.

8.

Physician Education: Myelodysplastic Syndrome.

Yoshida Y.

Oncologist. 1996;1(4):284-287.

9.

Cytokine expression in adherent layers from patients with myelodysplastic syndrome and acute myelogenous leukemia.

Wetzler M, Kurzrock R, Estrov Z, Estey E, Talpaz M.

Leuk Res. 1995 Jan;19(1):23-34.

PMID:
7837815
10.

Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture.

Engelhardt M, Mackenzie K, Drullinsky P, Silver RT, Moore MA.

Cancer Res. 2000 Feb 1;60(3):610-7.

11.

Stroma-dependent apoptosis in clonal hematopoietic precursors correlates with expression of PYCARD.

Mhyre AJ, Marcondes AM, Spaulding EY, Deeg HJ.

Blood. 2009 Jan 15;113(3):649-58. doi: 10.1182/blood-2008-04-152686. Epub 2008 Oct 22.

12.

Th22 cells as well as Th17 cells expand differentially in patients with early-stage and late-stage myelodysplastic syndrome.

Shao LL, Zhang L, Hou Y, Yu S, Liu XG, Huang XY, Sun YX, Tian T, He N, Ma DX, Peng J, Hou M.

PLoS One. 2012;7(12):e51339. doi: 10.1371/journal.pone.0051339. Epub 2012 Dec 7.

13.

[Abnormal polarization of T lymphocyte induces negative hematopoietic regulation in myelodysplastic syndromes].

Wu LY, Li X, Chang CK, Ying SX, Pu Q.

Zhonghua Xue Ye Xue Za Zhi. 2007 Aug;28(8):549-54. Chinese.

PMID:
18078133
14.

A systematic modeling study on the pathogenic role of p38 MAPK activation in myelodysplastic syndromes.

Peng H, Wen J, Zhang L, Li H, Chang CC, Zu Y, Zhou X.

Mol Biosyst. 2012 Apr;8(4):1366-74. doi: 10.1039/c2mb05184b. Epub 2012 Feb 10.

PMID:
22327869
15.

Negative regulators of hemopoiesis and stroma function in patients with myelodysplastic syndrome.

Deeg HJ, Beckham C, Loken MR, Bryant E, Lesnikova M, Shulman HM, Gooley T.

Leuk Lymphoma. 2000 Apr;37(3-4):405-14.

PMID:
10752992
16.

Survivin expression, apoptosis and proliferation in chronic myelomonocytic leukemia.

Invernizzi R, Travaglino E, Benatti C, Malcovati L, Della Porta M, Cazzola M, Ascari E.

Eur J Haematol. 2006 Jun;76(6):494-501. Epub 2006 Mar 9.

PMID:
16529600
17.

The bone marrow stem stromal imbalance--a key feature of disease progression in case of myelodysplastic mouse model.

Das M, Chatterjee S, Basak P, Das P, Pereira JA, Dutta RK, Chaklader M, Chaudhuri S, Law S.

J Stem Cells. 2010;5(2):49-64.

PMID:
22049615
18.

Burden of abnormal hematopoietic clone in patients with myelodysplastic syndromes.

Wang HQ, Shao ZH, Shi J, Cao YR, Liu H, Bai J, Tu MF, Xing LM, Cui ZZ, Liu SH, Sun J, Jia HR, Yang TY.

Chin Med Sci J. 2006 Jun;21(2):99-103.

PMID:
16845796
19.

Serum-free generation and quantification of functionally active Leukemia-derived DC is possible from malignant blasts in acute myeloid leukemia and myelodysplastic syndromes.

Kufner S, Fleischer RP, Kroell T, Schmid C, Zitzelsberger H, Salih H, de Valle F, Treder W, Schmetzer HM.

Cancer Immunol Immunother. 2005 Oct;54(10):953-70. Epub 2005 Mar 24.

PMID:
15789235
20.

Identification of DJ-1/PARK-7 as a determinant of stroma-dependent and TNF-alpha-induced apoptosis in MDS using mass spectrometry and phosphopeptide analysis.

Marcondes AM, Li X, Gooley TA, Milless B, Deeg HJ.

Blood. 2010 Mar 11;115(10):1993-2002. doi: 10.1182/blood-2009-08-236992. Epub 2010 Jan 8.

Supplemental Content

Support Center